Epidemiology of prostate cancer in India

Data from national cancer registries shows that incidence of certain cancers are on rise in India. The cancers which are showing significant increase in incidence rates include prostate, mouth and kidney among male population, corpus uteri, breast and thyroid among female population and lung cancer in both male and female populations. In the present review article we have focused on epidemiology of prostate cancer in Indian subcontinent in terms of incidence, survival, and mortality etc. The article presents the incidence rates, mortality and trends over time for prostate cancer as the data collected from national population based cancer registries. Prostate is the second leading site of cancer among males in large Indian cities like Delhi, Kolkatta, Pune and Thiruvananthapuram, third leading site of cancer in cities like Bangalore and Mumbai and it is among the top ten leading sites of cancers in the rest of the population based cancer registries (PBCRs) of India. The PBCRs at Bangalore (Annual Percentage Change: 3.4%), Chennai (4.2%), Delhi (3.3%), Mumbai (0.9%) and Kamrup Urban District (11.6%) recorded a statistically significant increasing trend in incidence rates over time.

• Publication year

  2014

• Venue

  Meta Gene

• Publication date

  2014-08-29

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.mgene.2014.07.007PMID 25606442PMCID 4287887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• International variation in prostate cancer incidence and mortality rates.

  2012cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010influential reference
• GLOBAL VARIATION IN CANCER INCIDENCE AND MORTALITY

  2001influential reference

• Survival outcomes in prostate cancer patients treated at an Indian tertiary care centre

  2026cites this paper
• A Deep Neural Network-Based Computer-Assisted Prostate Segmentation in Biparametric Magnetic Resonance Images

  2025cites this paper
• Evaluating the association of CYP17 and SRD5A2 gene polymorphisms with prostate Cancer risk: A case-control study in the male population of Jammu, India

  2025cites this paper
• Smoking and the risk of prostate cancer: a review of risk and disease progression

  2025cites this paper
• Identification of Factors Affecting Prostate Cancer Using Machine Learning Methods: A Systematic Review

  2025influential citation
• Understanding current trends and incidence projections of prostate cancer in India: A comprehensive analysis of national and regional data from the global burden of disease study (1990 -2021).

  2024cites this paper
• Beyond the Usual Suspects: When the Skin Tells a Different Story: Cutaneous Metastasis in Prostate Carcinoma

  2024cites this paper
• Synergistic Role of Green‐Synthesized Zinc Oxide Nanomaterials in Biomedicine Applications

  2024cites this paper
• Prostate cancer burden in major BRICS countries, 1990–2019: findings from the 2019 global burden of disease study

  2024cites this paper
• Effect of Prostate Cancer on Non-protein Nitrogenous Substances

  2024cites this paper
• Burden of Prostate Cancer, Prostate-specific Antigen Myths, and Optimal Prostate-specific Antigen Screening

  2024cites this paper
• Descriptive epidemiology of prostate cancer in India, 2012–2019: Insights from the National Cancer Registry Programme

  2024influential citation
• Possibilistic exponential spatial fuzzy clustering based cancer segmentation in multi-parametric prostate MRI

  2024cites this paper
• Role of Triple Antibody Cocktail, α-methyl acyl-CoA Racemase (AMACR/P504S), high-molecular-weight cytokeratin (HMWCK 34βE12), and Transformation-related protein 63 TP-63 or P63) in Distinguishing Suspicious Prostatic Lesions

  2024cites this paper
• Serum Prostate Specific Antigen and Mast Cells in Distinguishing Benign Prostatic Hyperplasia from Prostatic Carcinoma: Is there a Correlation?

  2023cites this paper
• Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer

  2023cites this paper
• Prostate cancer in India: Current perspectives and the way forward

  2023cites this paper
• Association of Non-Genetic Risk Factors with Prostate Cancer in the Population of Jammu Region of J and K, India

  2023cites this paper
• Grossing and reporting of radical prostatectomy specimens: An evidence-based approach.

  2023cites this paper
• A Computer-Aided Detection (CAD) System for the Recognition of Prostate Cancer Grounded on Classification

  2023cites this paper
• A comparative analysis of features and outcome of breast cancer in younger versus older women: A single center experience from Eastern Indian subcontinent

  2023cites this paper
• Molecular detection of urinary microbiome in prostate cancer patients

  2023cites this paper
• An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate – An institutional study

  2023cites this paper
• Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.

  2023cites this paper
• Expression of BAX and Bcl-2 gene in prostate carcinoma and its correlation with gleason score

  2023cites this paper
• Study of histomorphological spectrum of eyelid lesions

  2023cites this paper
• Role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting carcinoma prostate (CaP) in patients with lower urinary tract symptoms and raised serum prostate-specific antigen (sr.PSA).

  2023cites this paper
• Prostatic issues and Homoeopathic Approach

  2023cites this paper
• Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.

  2023cites this paper
• A comparative study of rectal volume variation in patients with prostate cancer: A tertiary care center study.

  2023cites this paper
• Determining age-specific prostate-specific antigen for healthy Indian men: A retrospective study

  2023cites this paper
• Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort

  2023influential citation
• Efficacy and Safety of Actinium-225 Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Prostate Cancer: A Systematic Review and Metanalysis

  2023cites this paper
• Computational approaches for evaluation of isobavachin as potential inhibitor against t877a and w741l mutations in prostate cancer

  2022influential citation
• Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer

  2022cites this paper
• Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods

  2022cites this paper
• Screening for Prostate Cancer: Role of Free Psa, Psad with Prostate Biopsy Findings and Digital Rectal Examination

  2022cites this paper
• Whole-exome sequencing of Indian prostate cancer reveals a novel therapeutic target: POLQ

  2022influential citation
• Role of transrectal ultrasound and elastography in the diagnosis of prostate lesions

  2022cites this paper
• Evaluation of Biochemical Recurrence and Correlation with Various Parameters After Robotic-Assisted Radical Prostatectomy: a Single Center Experience

  2022cites this paper
• Case Report Prostate health in India (BPH & Prostate Cancer)

  2022cites this paper
• Molecular basis of epigenetic regulation in cancer diagnosis and treatment

  2022cites this paper
• The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary)

  2022influential citation
• Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer.

  2022cites this paper
• Prostate health in India (BPH & Prostate Cancer)

  2022cites this paper
• Natural Products as the Modulators of Oxidative Stress: An Herbal Approach in the Management of Prostate Cancer.

  2022cites this paper
• Androgen Deprivation Therapy: A Ray Of Hope For Treating Early Stage For Prostate Cancer

  2021influential citation
• Flutamide Loaded Polymeric Nanoparticles for prostate Cancer: A Review

  2021cites this paper
• Parthenolide Induces Apoptosis and Cell Cycle Arrest by the Suppression of miR-375 Through Nucleolin in Prostate Cancer

  2021cites this paper
• Development of an Indian nomogram for predicting extracapsular extension in prostate cancer

  2021cites this paper
• TRANSRECTAL ULTRASONOGRAPHY AND MAGNETIC RESONANCE IMAGING (MRI) CORRELATION IN PATIENTS HAVING PROSTATIC PATHOLOGY.

  2021cites this paper
• Arginase, a Possible Therapeutic Target in Prostate Cancer

  2021cites this paper
• Bioengineered zinc oxide nanoparticles: Chemical, green, biological fabrication methods and its potential biomedical applications

  2021cites this paper
• Repurposing homeopathic drug Lachesis 200C as an anticancer activity: In vitro and in ovo study

  2021cites this paper
• Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

  2021cites this paper
• A prospective longitudinal study to evaluate bone health, implication of FRAX tool and impact on quality of life (FACT-P) in advanced prostate cancer patients.

  2021influential citation
• Proteomic profiling the molecular signatures of plectranthoic acid in prostate cancer cells.

  2021cites this paper
• Current Trends in Prevalence and Role of Long Noncoding RNA and Gene Fusion in Prostate Cancer: An Overview

  2021cites this paper
• Histomorphological Mimickers of benign prostatic lesions with prostatic adenocarcinoma

  2021cites this paper
• Hesperetin Modulates TGF- β Induced Invasion and Migration in Prostate Cancer Cells

  2021cites this paper
• Insights into association between urolithiasis and prostate cancer

  2021cites this paper
• A Prospective Study on the Efficacy of Cognitive Targeted Transrectal Ultrasound Prostate Biopsy in Diagnosing Clinically Significant Prostate Cancer

  2021influential citation
• Dietary energy density and risk of prostate cancer: (A case-control study).

  2021cites this paper
• A comprehensive mechanistic basis of prostate cancer advancement & its personalized implementation-bridging the gap: present state and future prospect

  2021influential citation
• RRU_A_300868 207..213

  2021influential citation
• Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2

  2021cites this paper
• Prognosis of breast cancer patients and survival rate related with Ki-67 proliferation index: multicenter retrospective study

  2021cites this paper
• Prostate cancer

  2021cites this paper
• Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer

  2021cites this paper
• BREAST CANCER IN RURAL BASED TERTIARY CENTER- AN AUDIT AND OUTCOME ANALYSIS

  2021cites this paper
• Prognostic Significance of the New Prostatic Carcinoma Grade Grouping System vis-à-vis Biochemical Recurrence: Experience from a Tertiary Care Centre in Dakshina Kannada District, Karnataka, India

  2021cites this paper
• Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer

  2021cites this paper
• Clinicopathological correlation of pre-biopsy quantitative PSMA uptake in patients with persistently raised serum PSA: initial experience in 74 patients with simultaneous 68-Ga PSMA PET/MRI

  2020cites this paper
• Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.

  2020cites this paper
• Sadyo maraneeyam of Bhela indriya sthana - An explorative study

  2020cites this paper
• Clinical outcome of Lu-177 PSMA in metastatic castration-resistant prostate cancer: An initial experience from a tertiary care cancer hospital

  2020cites this paper
• Determination of the optimal cut-off value of serum prostate-specific antigen in the prediction of skeletal metastases on technetium-99m whole-body bone scan by receiver operating characteristic curve analysis

  2020cites this paper
• 4,4′-Diisothiocyanatostilbene-2,2′-disulfonate modulates voltage-gated K+ current and influences cell cycle arrest in androgen sensitive and insensitive human prostate cancer cell lines

  2020cites this paper
• Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)

  2020cites this paper
• Diagnostic Accuracy of Prebiopsy Ga-68 PSMA PET/CT in Detecting Primary Prostate Carcinomas with Prostate-Specific Antigen <50 ng/ml

  2020cites this paper
• Genetic susceptibility of CYP1A1 gene and risk of pesticide exposure in prostate cancer

  2020cites this paper
• A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer

  2020cites this paper
• Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

  2020cites this paper
• A Pilot Study on the Whole Exome Sequencing of Prostate Cancer in the Indian Phenotype Reveals Distinct Polymorphisms

  2020cites this paper
• Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials.

  2020cites this paper
• Low-risk prostate cancer in India: Is active surveillance a valid treatment option?

  2020cites this paper
• Outcome of TRUS Biopsy with Limited Cores in Patients with PSA More Than 50 ng/dL: Can We Reduce the Number of Cores Without Affecting Outcomes?

  2020cites this paper
• Outcomes of standard 12-core transrectal ultrasound-guided prostate biopsy in biopsy naive Indian men -single center experience

  2020influential citation
• Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.

  2020cites this paper
• Histopathological study of prostatic lesions in correlation with serum prostate specific antigen levels in elderly men

  2020influential citation
• Experimental Animal Models for Prostate Cancer - A Mini Review

  2020cites this paper
• A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?

  2020cites this paper
• Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 1 of 2

  2020cites this paper
• Dosimetric comparison of single and double collimator stereotactic body radiotherapy plans using Cyber Knife for carcinoma prostate

  2020cites this paper
• Role of Transrectal Ultrasound Elastography in the Diagnosis of Prostate Carcinoma

  2020cites this paper
• Significance of neutrophil to lymphocyte ratio in prostate lesions with special reference to prostate cancer

  2020influential citation
• Examining Absorbed Doses of Indigenously Developed 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy

  2020cites this paper
• Castration aggravates insulin resistance, reduces immune function and improves quality of life of prostate cancer patients.

  2020cites this paper
• Correlation Of Total Prostate Specific Antigen With Levels Of Prolactin In Indian Patients With Prostate Cancer: A Preliminary Report

  2020cites this paper
• Prescribing practices for tumour aggressiveness and castration resistance in risk-stratified prostate cancer patients

  2020cites this paper